Vistagen Therapeutics (VTGN) Other Working Capital Changes (2010 - 2026)
Vistagen Therapeutics (VTGN) posted Other Working Capital Changes of -$734000.0 for Q1 2026, down 361.64% sequentially from -$159000.0 in Q4 2025, and down 14580.0% YoY from N/an in Q1 2025.
Vistagen Therapeutics (VTGN) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Vistagen Therapeutics has reported Other Working Capital Changes for 7 years, with the latest figure at -$734000.0 in Q1 2026.
- Quarterly Other Working Capital Changes fell 14580.0% year-over-year to -$734000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.2 million (down 190.05% YoY) and the FY2026 annual result came in at -$1.2 million, down 190.05% from the prior year.
- Other Working Capital Changes slipped to -$734000.0 in Q1 2026 per VTGN's latest filing, from -$159000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $1.9 million in Q2 2025 and troughed at -$1.9 million in Q3 2025.
- A 5-year average of -$225326.7 and a median of -$150100.0 in 2023 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2023 and 2026: Other Working Capital Changes jumped 948.4% in 2023, then plunged 14580.0% in 2026.
- Over 5 years, Other Working Capital Changes stood at -$109500.0 in 2022, then surged by 948.4% to $929000.0 in 2023, then sank by 108.72% to -$81000.0 in 2024, then sank by 96.3% to -$159000.0 in 2025, then sank by 361.64% to -$734000.0 in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$734000.0, -$159000.0, and -$77000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn |
| 4 | Moderna | 59.81 Bn | 54.67 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.87 Bn | 28.56 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - |
| 10 | Vistagen Therapeutics | 10.50 Mn | 10.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -82,000.00 |
| Mar 31, 2026 | -82,000.00 |
| Mar 31, 2026 | -82,000.00 |
| Dec 31, 2025 | 9,000.00 |
| Dec 31, 2025 | 9,000.00 |
| Dec 31, 2025 | 9,000.00 |
| Sep 30, 2025 | -1.91 Mn |
| Sep 30, 2025 | -1.91 Mn |
| Sep 30, 2025 | -1.91 Mn |
| Jun 30, 2025 | 1.94 Mn |
| Jun 30, 2025 | 1.94 Mn |
| Jun 30, 2025 | 1.94 Mn |
| Mar 31, 2025 | 213,000.00 |
| Mar 31, 2025 | 213,000.00 |
| Mar 31, 2025 | 213,000.00 |
| Dec 31, 2024 | -989,000.00 |
| Dec 31, 2024 | -989,000.00 |
| Dec 31, 2024 | -989,000.00 |
| Sep 30, 2024 | -104,000.00 |
| Sep 30, 2024 | -104,000.00 |